Benchmarking Deployment of eHealth among General Practitioners (2013)

This is the final report of the study "Benchmarking deployment of eHealth among General Practitioners II" funded by Unit F4 of DG CONNECT. A survey of General Practitioners (GPs) was conducted in 31 countries (EU27+ Croatia, Iceland, Norway, and Turkey) to measure and explain levels of availability and use (adoption) of eHealth applications and services. A random sample of 9,196 GPs was interviewed and data was processed using sophisticate multivariate statistical techniques. The survey shows that access to, and use of, basic ICT (a computer connected to the Internet) in the consultation room has become almost universal in all countries (97% of the sample). For more advanced features such as Electronic Health Records (EHR), Health Information Exchange (HIE), Telehealth, and Personal Health Records (PHR), however, the data show that more progress is needed. Although there was progress compared to 2007, adoption of eHealth systems in primary care is still limited for HIE, Telehealth, and PHR. Some basic forms of EHR are now available to about 93% of GPs, but more advanced features are less widespread. Levels of adoption are influenced by GPs individual characteristics and attitudes as well as by country level effects, and by the perception of impacts and barriers. The majority of GPs place more emphasis on barriers than on benefits, and identify lack of financial incentives and resources, lack of inter-operability, and lack of a regulatory framework on issues of confidentiality and privacy as the main barriers. The levels of adoption registered suggest that we are still very far from reaching the target and objectives defined for eHealth both in the Digital Agenda for Europe and in the 2012 eHealth Action Plan, and that more policy efforts are need to facilitate uptake.

Download:

Most Popular Now

Open Call HORIZON-JU-IHI-2022-03-05: Dig…

Mental health disorders represent an area of severe unmet public health need. This has been further negatively impacted by the COVID-19 pandemic, with a substantial increase in the number and...

The Future of Medicine is Data

At the 2023 Annual J.P. Morgan Healthcare Conference, Owkin Co-founder and CEO Thomas Clozel, MD will outline how data is the future of medicine - from the development of new...

Brain Area Necessary for Fluid Intellige…

A team led by UCL and UCLH researchers have mapped the parts of the brain that support our ability to solve problems without prior experience - otherwise known as fluid...

Study Surveys Landscape of Apps Built on…

A study led by Regenstrief Institute Research Scientist Titus K. Schleyer, DMD, PhD, is among the first to survey the current landscape of FHIR® apps, providing a snapshot of how...

New Computer Program 'Learns' to Identif…

Genetic mutations cause hundreds of unsolved and untreatable disorders. Among them, DNA mutations in a small percentage of cells, called mosaic mutations, are extremely difficult to detect because they exist...

Applications Open for SpinLab Accelerato…

The start-up accelerator supports entrepreneurial and innovative teams that want to grow sustainably and successfully scale their business model. With a strong hands-on mentality and a lot of passion, the...

Allscripts Announces Corporate Name Chan…

Allscripts Healthcare Solutions, Inc. announced that, effective January 1, 2023, it has changed its name to Veradigm Inc. (NASDAQ: MDRX). Allscripts had been transitioning its solutions to the Veradigm brand...

Bayer to Accelerate Drug Discovery with …

Bayer AG and Google Cloud today announced a collaboration to drive early drug discovery that will apply Google Cloud's Tensor Processing Units (TPUs), which are custom-developed accelerators designed to run...

220M€ Investment in Testing and Experime…

To make the EU the place where AI excellence thrives from the lab to the market, the European Union is setting up world-class Testing and Experimentation Facilities (TEFs) for AI. Together...

Artificial Nerve Cells - Almost Like Bio…

Researchers at Linköping University (LiU), Sweden, have created an artificial organic neuron that closely mimics the characteristics of biological nerve cells. This artificial neuron can stimulate natural nerves, making it...

AI Tool Developed to Predict Risk of Lun…

Lung cancer is the leading cause of cancer death in the United States and around the world. Low-dose chest computed tomography (LDCT) is recommended to screen people between 50 and...

For Shared Decision-Making, Telemedicine…

Telemedicine may be just as effective as in-person visits when it comes to shared decision-making and communication for patients undergoing a first-time surgery consultation, according to a study published as...